Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo [Corrigendum]

Zhang L, Wang TT, Li Q, et al. Int J Nanomedicine. 2016;11:2663–2673.Following a review of their data post-publication, the authors found errors in the kidney and PPT group image used for Figure 7 on page 2671 and the spleen control and PP group images a...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhang L, Wang TT, Li Q, Huang J, Xu H, Li J, Wang Y, Liang Q
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/08631526ab394bd0908cfe78342da9b9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:08631526ab394bd0908cfe78342da9b9
record_format	dspace
spelling	oai:doaj.org-article:08631526ab394bd0908cfe78342da9b92021-12-02T05:40:27ZFabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo [Corrigendum]1178-2013https://doaj.org/article/08631526ab394bd0908cfe78342da9b92019-04-01T00:00:00Zhttps://www.dovepress.com/corrigendum-fabrication-of-novel-vesicles-of-triptolide-for-antir-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Zhang L, Wang TT, Li Q, et al. Int J Nanomedicine. 2016;11:2663–2673.Following a review of their data post-publication, the authors found errors in the kidney and PPT group image used for Figure 7 on page 2671 and the spleen control and PP group images and liver PP and PPT group images used for Figure 8 on page 2671. For accuracy and experimental integrity these images have been corrected, with no impact to the conclusions of the study. The authors apologize for these errors. Read the original article  Zhang LWang TTLi QHuang JXu HLi JWang YLiang QDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 2755-2756 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 Zhang L Wang TT Li Q Huang J Xu H Li J Wang Y Liang Q Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo [Corrigendum]
description	Zhang L, Wang TT, Li Q, et al. Int J Nanomedicine. 2016;11:2663–2673.Following a review of their data post-publication, the authors found errors in the kidney and PPT group image used for Figure 7 on page 2671 and the spleen control and PP group images and liver PP and PPT group images used for Figure 8 on page 2671. For accuracy and experimental integrity these images have been corrected, with no impact to the conclusions of the study. The authors apologize for these errors. Read the original article
format	article
author	Zhang L Wang TT Li Q Huang J Xu H Li J Wang Y Liang Q
author_facet	Zhang L Wang TT Li Q Huang J Xu H Li J Wang Y Liang Q
author_sort	Zhang L
title	Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo [Corrigendum]
title_short	Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo [Corrigendum]
title_full	Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo [Corrigendum]
title_fullStr	Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo [Corrigendum]
title_full_unstemmed	Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo [Corrigendum]
title_sort	fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo [corrigendum]
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/08631526ab394bd0908cfe78342da9b9
work_keys_str_mv	AT zhangl fabricationofnovelvesiclesoftriptolideforantirheumatoidactivitywithreducedtoxicityinvitroandinvivocorrigendum AT wangtt fabricationofnovelvesiclesoftriptolideforantirheumatoidactivitywithreducedtoxicityinvitroandinvivocorrigendum AT liq fabricationofnovelvesiclesoftriptolideforantirheumatoidactivitywithreducedtoxicityinvitroandinvivocorrigendum AT huangj fabricationofnovelvesiclesoftriptolideforantirheumatoidactivitywithreducedtoxicityinvitroandinvivocorrigendum AT xuh fabricationofnovelvesiclesoftriptolideforantirheumatoidactivitywithreducedtoxicityinvitroandinvivocorrigendum AT lij fabricationofnovelvesiclesoftriptolideforantirheumatoidactivitywithreducedtoxicityinvitroandinvivocorrigendum AT wangy fabricationofnovelvesiclesoftriptolideforantirheumatoidactivitywithreducedtoxicityinvitroandinvivocorrigendum AT liangq fabricationofnovelvesiclesoftriptolideforantirheumatoidactivitywithreducedtoxicityinvitroandinvivocorrigendum
_version_	1718400273684103168

Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo [Corrigendum]

Ejemplares similares